rifaximin causes resistance to daptomycin

This is a news story, published by Guardian, that relates primarily to Daptomycin news.

Daptomycin news

For more Daptomycin news, you can click here:

more Daptomycin news

video games news

For more video games news, you can click here:

Guardian news

For more news from Guardian, you can click here:

more news from Guardian

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best entertainment news, business news, world news, and much more. If you like video games news, you might also like this article about

antibiotic resistance

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest antimicrobial resistance news, antibiotics news, video games news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

risk antibiotic

Guardian

•

Rise of almost untreatable superbug linked to a common antibiotic

Summary

Nutrition label

81% Informative

Rifaximin, an antibiotic used to treat liver disease, causes resistance to another antibiotic.

Daptomycin is one of the few drugs that is effective against vancomycin-resistant enterococcus (VRE), a contagious bacterial infection that can cause serious reactions in hospitalised patients.

It was previously thought the risk of antibiotic resistance only applied to one antibiotic.

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech